451
Participants
Start Date
October 28, 2020
Primary Completion Date
August 30, 2023
Study Completion Date
August 30, 2023
Mayzent
There is no treatment allocation. Patients administered Mayzent by prescription that have started before inclusion of the patient into the study will be enrolled.
Novartis Investigative Site, Anjo
Novartis Investigative Site, Hekinan
Novartis Investigative Site, Ichinomiya
Novartis Investigative Site, Kariya
Novartis Investigative Site, Kasugai
Novartis Investigative Site, Nagakute
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Seto
Novartis Investigative Site, Hachinohe
Novartis Investigative Site, Hirosaki
Novartis Investigative Site, Ichihara
Novartis Investigative Site, Ichikawa
Novartis Investigative Site, Yachiyo
Novartis Investigative Site, Tōon
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Kitakyushu
Novartis Investigative Site, Kitakyushu
Novartis Investigative Site, Kitakyushu
Novartis Investigative Site, Kurume
Novartis Investigative Site, Gifu
Novartis Investigative Site, Gifu
Novartis Investigative Site, Isesaki
Novartis Investigative Site, Maebashi
Novartis Investigative Site, Maebashi
Novartis Investigative Site, Ōta
Novartis Investigative Site, Fukuyama
Novartis Investigative Site, Kure
Novartis Investigative Site, Asahikawa
Novartis Investigative Site, Hakodate
Novartis Investigative Site, Iwamizawa
Novartis Investigative Site, Kitami
Novartis Investigative Site, Kushiro
Novartis Investigative Site, Muroran
Novartis Investigative Site, Rumoi
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Sapporo
Novartis Investigative Site, Ako
Novartis Investigative Site, Awaji
Novartis Investigative Site, Itami
Novartis Investigative Site, Kobe
Novartis Investigative Site, Kobe
Novartis Investigative Site, Nishinomiya
Novartis Investigative Site, Hitachi
Novartis Investigative Site, Hitachi-Naka
Novartis Investigative Site, Toride
Novartis Investigative Site, Tsuchiura
Novartis Investigative Site, Tsukuba
Novartis Investigative Site, Tsukuba
Novartis Investigative Site, Kanazawa
Novartis Investigative Site, Hanamaki
Novartis Investigative Site, Ichinoseki
Novartis Investigative Site, Kita-gun
Novartis Investigative Site, Kagoshima
Novartis Investigative Site, Kamikoshikichō-oshima
Novartis Investigative Site, Ashigarakami
Novartis Investigative Site, Atsugi
Novartis Investigative Site, Hiratsuka
Novartis Investigative Site, Isehara
Novartis Investigative Site, Kawasaki
Novartis Investigative Site, Sagamihara
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Yokohama
Novartis Investigative Site, Yokosuka
Novartis Investigative Site, Nankoku
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Kyoto
Novartis Investigative Site, Suzuka
Novartis Investigative Site, Tsu
Novartis Investigative Site, Kesennuma
Novartis Investigative Site, Sendai
Novartis Investigative Site, Miyakonojō
Novartis Investigative Site, Chiisagata
Novartis Investigative Site, Iida
Novartis Investigative Site, Ina
Novartis Investigative Site, Kitaazumi
Novartis Investigative Site, Matsumoto
Novartis Investigative Site, Matsumoto
Novartis Investigative Site, Nagano
Novartis Investigative Site, Saku
Novartis Investigative Site, Suwa
Novartis Investigative Site, Sasebo
Novartis Investigative Site, Kashihara
Novartis Investigative Site, Nagaoka
Novartis Investigative Site, Nagaoka
Novartis Investigative Site, Niigata
Novartis Investigative Site, Tsubame
Novartis Investigative Site, Tsubame
Novartis Investigative Site, Beppu
Novartis Investigative Site, Ōita
Novartis Investigative Site, Usa
Novartis Investigative Site, Yufu
Novartis Investigative Site, Okayama
Novartis Investigative Site, Okayama
Novartis Investigative Site, Ginowan
Novartis Investigative Site, Fujiidera
Novartis Investigative Site, Higashiosaka
Novartis Investigative Site, Osaka
Novartis Investigative Site, Ōsaka-sayama
Novartis Investigative Site, Sakai
Novartis Investigative Site, Suita
Novartis Investigative Site, Takatsuki
Novartis Investigative Site, Saga
Novartis Investigative Site, Ageo
Novartis Investigative Site, Iruma-gun
Novartis Investigative Site, Kawagoe
Novartis Investigative Site, Koshigaya
Novartis Investigative Site, Koshigaya
Novartis Investigative Site, Wako
Novartis Investigative Site, Ohtsu-city
Novartis Investigative Site, Ōmihachiman
Novartis Investigative Site, Izumo
Novartis Investigative Site, Fuji
Novartis Investigative Site, Hamamatsu
Novartis Investigative Site, Izunokuni
Novartis Investigative Site, Oyama
Novartis Investigative Site, Shimotsuke
Novartis Investigative Site, Adachi City
Novartis Investigative Site, Adachi-ku
Novartis Investigative Site, Bunkyo Ku
Novartis Investigative Site, Bunkyo Ku
Novartis Investigative Site, Bunkyo-ku
Novartis Investigative Site, Edogawa City
Novartis Investigative Site, Fuchū
Novartis Investigative Site, Fuchū
Novartis Investigative Site, Hachiōji
Novartis Investigative Site, Hachiōji
Novartis Investigative Site, Itabashi Ku
Novartis Investigative Site, Kodaira
Novartis Investigative Site, Meguro City
Novartis Investigative Site, Nakano City
Novartis Investigative Site, Ōta-ku
Novartis Investigative Site, Ōta-ku
Novartis Investigative Site, Ōta-ku
Novartis Investigative Site, Shinagawa-ku
Novartis Investigative Site, Shinjuku Ku
Novartis Investigative Site, Shinjuku-ku
Novartis Investigative Site, Shinjuku-ku
Novartis Investigative Site, Kurayoshi
Novartis Investigative Site, Toyama
Novartis Investigative Site, Sakata
Novartis Investigative Site, Shimonoseki
Novartis Investigative Site, Shūnan
Novartis Investigative Site, Ube
Novartis Investigative Site, Akita
Novartis Investigative Site, Aomori
Novartis Investigative Site, Chiba
Novartis Investigative Site, Fukui
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Gifu
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Hiroshima
Novartis Investigative Site, Kagoshima
Novartis Investigative Site, Kagoshima
Novartis Investigative Site, Kochi
Novartis Investigative Site, Kumamoto
Novartis Investigative Site, Kyoto
Novartis Investigative Site, Kyoto
Novartis Investigative Site, Nagasaki
Novartis Investigative Site, Nagasaki
Novartis Investigative Site, Niigata
Novartis Investigative Site, Osaka
Novartis Investigative Site, Ōita
Novartis Investigative Site, Saga
Novartis Investigative Site, Saitama
Novartis Investigative Site, Shizuoka
Novartis Investigative Site, Tokushima
Novartis Investigative Site, Tokushima
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY